Rickerts Volker, Mousset Sabine, Lambrecht Evelyn, Tintelnot Kathrin, Schwerdtfeger Rainer, Presterl Elisabeth, Jacobi Volkmar, Just-Nübling Gudrun, Bialek Ralf
Department of Internal Medicine II, University Hospital, Frankfurt, Germany.
Clin Infect Dis. 2007 Apr 15;44(8):1078-83. doi: 10.1086/512812. Epub 2007 Mar 5.
With the advent of new antifungal agents, the identification of a causative pathogen is crucial to guide the antifungal treatment of invasive mold infection. However, tissue cultures often fail to grow a fungal pathogen in cases of suspected mold infection.
In a prospective multicenter study, we compared the results of histopathological analysis, culture, and 2 seminested polymerase chain reaction assays identifying Aspergillus species and Zygomycetes as causative agents of invasive mold infections using respiratory tract biopsy samples obtained from 56 immunocompromised patients who had suspected mold infection.
Mold hyphae were detected histopathologically in 27 (48%) of the tissue specimens. Hyphae corresponded to either aspergillosis (n=18) or zygomycosis (n=6) or could not be further specified (n=3). A mold was cultured from 14 of 18 samples with aspergillus hyphae, 2 of 6 samples with Zygomycetes hyphae, and 1 of 3 samples with unspecified hyphae. Polymerase chain reaction was superior to culture in detecting the infecting mold (26 of 27 samples vs. 17 of 27 samples, respectively; P=.006) from histopathologically positive samples. Genus or species identification by sequencing of the polymerase chain reaction products were in accordance with culture results in 16 of 18 culture-positive samples. Both polymerase chain reaction assays failed to detect fungal DNA in 1 sample that had unspecified hyphae and negative culture results.
The PCR assays offer a reliable etiologic diagnosis that is superior to culture in patients with proven invasive mold infection. This may improve patient management through tailored antifungal therapy when cultures fail to grow a pathogen.
随着新型抗真菌药物的出现,确定致病病原体对于指导侵袭性霉菌感染的抗真菌治疗至关重要。然而,在疑似霉菌感染的病例中,组织培养往往无法培养出真菌病原体。
在一项前瞻性多中心研究中,我们比较了组织病理学分析、培养以及两种半巢式聚合酶链反应检测的结果,这些检测使用从56例疑似霉菌感染的免疫功能低下患者的呼吸道活检样本中鉴定曲霉菌属和接合菌纲作为侵袭性霉菌感染的病原体。
在27份(48%)组织标本中通过组织病理学检测到霉菌菌丝。菌丝对应于曲霉菌病(n = 18)或毛霉菌病(n = 6),或者无法进一步明确(n = 3)。从18份有曲霉菌菌丝的样本中的14份、6份有接合菌纲菌丝的样本中的2份以及3份有未明确菌丝的样本中的1份培养出了霉菌。聚合酶链反应在从组织病理学阳性样本中检测感染性霉菌方面优于培养(分别为27份样本中的26份与27份样本中的17份;P = 0.006)。通过对聚合酶链反应产物进行测序来鉴定属或种与18份培养阳性样本中的16份的培养结果一致。两种聚合酶链反应检测均未能在1份有未明确菌丝且培养结果为阴性的样本中检测到真菌DNA。
聚合酶链反应检测为确诊的侵袭性霉菌感染患者提供了一种可靠的病因诊断,其优于培养。当培养未能培养出病原体时,这可能通过定制的抗真菌治疗改善患者管理。